Transcat, Inc. (NASDAQ:TRNS) Director Paul D. Moore sold 4,000 shares of the company’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $13.00, for a total value of $52,000.00. Following the transaction, the director now directly owns 57,698 shares of the company’s stock, valued at $750,074. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Transcat, Inc. (NASDAQ:TRNS) traded up 1.1878% during trading on Tuesday, hitting $13.3062. The stock had a trading volume of 10,179 shares. The stock has a 50-day moving average price of $12.49 and a 200-day moving average price of $12.06. The company has a market cap of $94.75 million, a PE ratio of 21.1210 and a beta of 0.34. Transcat, Inc. has a 52 week low of $9.97 and a 52 week high of $14.05.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 earnings per share (EPS) for the quarter. Transcat had a net margin of 3.03% and a return on equity of 10.54%. The firm had revenue of $36.28 million during the quarter. Equities analysts predict that Transcat, Inc. will post $0.64 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was first reported by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/08/08/transcat-inc-trns-director-paul-d-moore-sells-4000-shares.html.

Hedge funds and other institutional investors have recently bought and sold shares of the company. QCI Asset Management Inc. NY raised its position in Transcat by 10.0% in the second quarter. QCI Asset Management Inc. NY now owns 24,587 shares of the scientific and technical instruments company’s stock valued at $299,000 after buying an additional 2,226 shares during the period. Neuberger Berman Group LLC raised its position in Transcat by 3.1% in the second quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after buying an additional 4,900 shares during the period. Finally, WCM Investment Management CA raised its position in Transcat by 0.7% in the second quarter. WCM Investment Management CA now owns 480,332 shares of the scientific and technical instruments company’s stock valued at $5,836,000 after buying an additional 3,545 shares during the period. 57.73% of the stock is owned by hedge funds and other institutional investors.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with MarketBeat.com's FREE daily email newsletter.